vs

Side-by-side financial comparison of ALLIANCE ENTERTAINMENT HOLDING CORP (AENT) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $368.7M, roughly 1.3× ALLIANCE ENTERTAINMENT HOLDING CORP). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.5%, a 4.3% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -6.3%). Over the past eight quarters, ALLIANCE ENTERTAINMENT HOLDING CORP's revenue compounded faster (32.1% CAGR vs -0.1%).

Alliance Atlantis Communications Inc. was a media company that operated primarily as a specialty service provider in Canada. Primarily based in Toronto, Alliance Atlantis also had offices in Halifax, Los Angeles, London, Dublin, Madrid, Barcelona, Shannon, and Sydney.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

AENT vs MD — Head-to-Head

Bigger by revenue
MD
MD
1.3× larger
MD
$493.8M
$368.7M
AENT
Growing faster (revenue YoY)
MD
MD
+4.6% gap
MD
-1.7%
-6.3%
AENT
Higher net margin
MD
MD
4.3% more per $
MD
6.8%
2.5%
AENT
Faster 2-yr revenue CAGR
AENT
AENT
Annualised
AENT
32.1%
-0.1%
MD

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AENT
AENT
MD
MD
Revenue
$368.7M
$493.8M
Net Profit
$9.4M
$33.7M
Gross Margin
Operating Margin
4.7%
9.9%
Net Margin
2.5%
6.8%
Revenue YoY
-6.3%
-1.7%
Net Profit YoY
32.8%
10.5%
EPS (diluted)
$0.18
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AENT
AENT
MD
MD
Q4 25
$368.7M
$493.8M
Q3 25
$254.0M
$492.9M
Q2 25
$227.8M
$468.8M
Q1 25
$213.0M
$458.4M
Q4 24
$393.7M
$502.4M
Q3 24
$229.0M
$511.2M
Q2 24
$236.9M
$504.3M
Q1 24
$211.2M
$495.1M
Net Profit
AENT
AENT
MD
MD
Q4 25
$9.4M
$33.7M
Q3 25
$4.9M
$71.7M
Q2 25
$5.8M
$39.3M
Q1 25
$1.9M
$20.7M
Q4 24
$7.1M
$30.5M
Q3 24
$397.0K
$19.4M
Q2 24
$2.5M
$-153.0M
Q1 24
$-3.4M
$4.0M
Operating Margin
AENT
AENT
MD
MD
Q4 25
4.7%
9.9%
Q3 25
4.2%
13.8%
Q2 25
4.3%
12.8%
Q1 25
1.7%
7.0%
Q4 24
3.8%
7.8%
Q3 24
0.9%
6.6%
Q2 24
0.2%
-31.3%
Q1 24
-0.3%
3.2%
Net Margin
AENT
AENT
MD
MD
Q4 25
2.5%
6.8%
Q3 25
1.9%
14.5%
Q2 25
2.5%
8.4%
Q1 25
0.9%
4.5%
Q4 24
1.8%
6.1%
Q3 24
0.2%
3.8%
Q2 24
1.1%
-30.3%
Q1 24
-1.6%
0.8%
EPS (diluted)
AENT
AENT
MD
MD
Q4 25
$0.18
$0.40
Q3 25
$0.10
$0.84
Q2 25
$0.11
$0.46
Q1 25
$0.04
$0.24
Q4 24
$0.14
$0.37
Q3 24
$0.01
$0.23
Q2 24
$0.05
$-1.84
Q1 24
$-0.07
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AENT
AENT
MD
MD
Cash + ST InvestmentsLiquidity on hand
$375.2M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$117.6M
$865.9M
Total Assets
$434.1M
$2.2B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AENT
AENT
MD
MD
Q4 25
$375.2M
Q3 25
$340.1M
Q2 25
$224.7M
Q1 25
$99.0M
Q4 24
$229.9M
Q3 24
$4.3M
$103.8M
Q2 24
$1.1M
$19.4M
Q1 24
$1.6M
$8.0M
Total Debt
AENT
AENT
MD
MD
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AENT
AENT
MD
MD
Q4 25
$117.6M
$865.9M
Q3 25
$108.1M
$890.7M
Q2 25
$103.2M
$833.8M
Q1 25
$97.4M
$789.2M
Q4 24
$95.6M
$764.9M
Q3 24
$88.0M
$732.5M
Q2 24
$87.6M
$706.5M
Q1 24
$85.1M
$856.2M
Total Assets
AENT
AENT
MD
MD
Q4 25
$434.1M
$2.2B
Q3 25
$383.0M
$2.2B
Q2 25
$361.2M
$2.1B
Q1 25
$349.4M
$2.0B
Q4 24
$401.7M
$2.2B
Q3 24
$395.7M
$2.1B
Q2 24
$340.8M
$2.0B
Q1 24
$324.0M
$2.2B
Debt / Equity
AENT
AENT
MD
MD
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AENT
AENT
MD
MD
Operating Cash FlowLast quarter
$-16.5M
$114.1M
Free Cash FlowOCF − Capex
$-16.9M
FCF MarginFCF / Revenue
-4.6%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-1.76×
3.39×
TTM Free Cash FlowTrailing 4 quarters
$-1.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AENT
AENT
MD
MD
Q4 25
$-16.5M
$114.1M
Q3 25
$2.7M
$137.3M
Q2 25
$10.7M
$137.2M
Q1 25
$2.5M
$-117.5M
Q4 24
$25.3M
$133.0M
Q3 24
$-11.6M
$91.8M
Q2 24
$9.7M
$107.0M
Q1 24
$20.0M
$-125.2M
Free Cash Flow
AENT
AENT
MD
MD
Q4 25
$-16.9M
Q3 25
$2.4M
Q2 25
$10.7M
Q1 25
$2.4M
Q4 24
Q3 24
$-11.6M
Q2 24
Q1 24
$20.0M
FCF Margin
AENT
AENT
MD
MD
Q4 25
-4.6%
Q3 25
0.9%
Q2 25
4.7%
Q1 25
1.1%
Q4 24
Q3 24
-5.1%
Q2 24
Q1 24
9.4%
Capex Intensity
AENT
AENT
MD
MD
Q4 25
0.1%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
Q1 24
0.0%
Cash Conversion
AENT
AENT
MD
MD
Q4 25
-1.76×
3.39×
Q3 25
0.56×
1.91×
Q2 25
1.86×
3.49×
Q1 25
1.33×
-5.66×
Q4 24
3.57×
4.36×
Q3 24
-29.31×
4.72×
Q2 24
3.85×
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AENT
AENT

Segment breakdown not available.

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons